- InMode (INMD, Financial) anticipates Q1 2025 revenue between $77.2 million and $77.5 million.
- The company projects a non-GAAP gross margin of 78-79% for the quarter.
- InMode reiterates its full-year 2025 revenue guidance between $395 million and $405 million.
InMode Ltd. (INMD), a leading global provider of innovative medical technologies, has announced its preliminary financial expectations for the first quarter of 2025, ahead of a scheduled earnings call. The company expects to report Q1 2025 revenue ranging from $77.2 million to $77.5 million, with a strong non-GAAP gross margin projected between 78% and 79%, indicating robust pricing power in the competitive medical device market.
InMode has maintained its full-year 2025 revenue guidance, anticipating between $395 million and $405 million. This guidance suggests that management expects stronger performance in the remaining quarters to meet the annual target.
The company's Q1 2025 earnings conference call is scheduled for Monday, April 28, 2025, at 8:30 a.m. Eastern Time. Key insights will be shared by Moshe Mizrahy, Chief Executive Officer, Yair Malca, Chief Financial Officer, and Dr. Michael Kreindel, Chief Technology Officer. The call will be accessible via various toll-free numbers and a webcast on InMode's website, with a replay available until May 12, 2025.
